Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday.

"No one is going to prevent the people of Massachusetts from getting the health care they need," she said. Six years ago, the school refused to ordain a gay student as a rabbi. A lot has changed ...